ACE inhibitors during the first trimester MIGHT increase the risk of birth defects

July 2006

A new study suggests that using ACE inhibitors during the first trimester MIGHT increase the risk of birth defects.

This is a surprise.

We know that exposure to ACE inhibitors and ARBs during the second and third trimesters increases the risk of fetal death.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote